ULCAMED

This brand name is authorized in Austria, Estonia, Croatia, Lithuania, Romania

Active ingredients

The drug ULCAMED contains one active pharmaceutical ingredient (API):

1 Tripotassium dicitrato bismuthate UNII HS813P8QPX - BISMUTH SUBCITRATE

Under the effect of gastric acid, a precipitate is formed from tripotassium dicitrato bismuthate, which adheres primarily to the ulcerated area and inhibits the activity of pepsin. Tripotassium dicitrato bismuthate contributes to the healing of a high percentage of gastric and duodenal ulcers. Read about Tripotassium dicitrato bismuthate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A02BX05	Bismuth subcitrate	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
Discover more medicines within A02BX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1749450, 1749461, 1749472, 1749483, 1749494, 1749506, 1749517
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-123794053
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1084639, 1084640, 1084641, 1084642, 1084643, 1084644, 1084645, 1089823
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W62392001, W62392002, W62392003, W62392004, W62392005, W62392006, W62392007